Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 CAD | -1.69% | -2.11% | +17.72% |
Apr. 08 | HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA | CI |
Mar. 14 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.72% | 110M | |
+17.35% | 70.95B | |
+5.38% | 8.67B | |
+6.69% | 8.16B | |
-20.96% | 7.91B | |
+0.49% | 4.51B | |
+17.12% | 4.31B | |
-3.38% | 4.07B | |
-2.61% | 3.84B | |
+22.08% | 3.63B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- Transcript : HLS Therapeutics Inc. - Special Call